Skip to content

Clinical trial on the health benefits of Perfect Brand Seabuckthorn Garlic Soft Capsules in maintaining healthy levels of blood lipids (cholesterol/triglycerides)

Clinical trial on the health benefits of Perfect Brand Seabuckthorn Garlic Soft Capsules in maintaining healthy levels of blood lipids (cholesterol/triglycerides)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092191
Enrollment
Unknown
Registered
2024-11-12
Start date
2024-11-13
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia

Interventions

test group:Perfect Brand Seabuckthorn Garlic Soft Capsules
control group:placebo

Sponsors

The 983rd Hospital of the Chinese People's Liberation Army Joint Logistic Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Under normal dietary conditions, blood lipid levels should be measured after fasting for 12-14 hours. At least two blood lipid tests should be conducted within six months, with serum total cholesterol levels between 5.18-6.21mmol/L and serum triglycerides between 1.70-2.25mmol/L, which can be used as alternative subjects for functional tests that help maintain healthy blood lipid levels. 2.Obtaining informed consent and voluntarily participating in the trial.

Exclusion criteria

Exclusion criteria: 1. Individuals under the age of 18 or over the age of 65. 2. Pregnant or lactating women, those with allergies or those who are allergic to the test sample. 3. Patients with severe illnesses of the heart, liver, kidney, hematopoietic system, and psychiatric disorders. 4. Has taken lipid-lowering drugs in the past two weeks, which has affected the judgment of the results. 5. Hyperlipidemic patients. 6. Those who have not consumed the test sample according to regulations, or whose information is incomplete, which affects the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Eight types of blood lipids (total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, very low-density lipoprotein, apolipoprotein A1, apolipoprotein B, lipoprotein a);

Secondary

MeasureTime frame
HMGCoA;Fasting blood glucose;glycosylated hemoglobin;Lipopolysaccharide;Toll-like receptor 4;C-reactive protein;Serum Metabolome;Fecal metagenome and metabolome;

Countries

China

Contacts

Public ContactMeng Yongxia

The 983rd Hospital of the Chinese People's Liberation Army Joint Logistic Support Force

kangaotech@aliyun.com+86 170 3299 0000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026